Back

A reliability-screened thalamocortical control-network phenotype tracks cocaine-use history in cocaine use disorder

Edelman, B. B.; Skolnick, J.

2026-04-29 addiction medicine
10.64898/2026.04.28.26351962 medRxiv
Show abstract

BackgroundA central goal in psychiatry is to move from symptom-defined diagnoses toward biologically interpretable and reliable phenotypes. In cocaine use disorder (CUD), many resting-state abnormalities have been reported, but few circuit-level findings have been explicitly screened for reliability. We tested whether prespecified thalamocortical features yield a reproducible phenotype in CUD and whether that phenotype reflects diagnosis, recent cocaine use, or longer-term illness history. MethodsDiscovery analyses used resting-state data from 105 participants (46 healthy controls, 59 CUD). From a 13-region thalamocortical circuit, we derived an HC-trained LEiDA state model, generated 11 prespecified features, and advanced only those meeting split-half reliability criteria (ICC[3,1] [≥]0.40). A separate paired TMS sample (n=44) was used for extension analyses. ResultsFive features survived reliability screening. Within CUD, longer duration since beginning cocaine use was associated with greater occupancy of a control-like state (standardized {beta}=0.37, q=0.005) and stronger whole-thalamus connectivity with control frontoparietal cortex (standardized {beta}=0.30, q=0.018). Neither days since last use nor CUD vs. healthy diagnosis were associated with any reliable feature after correction. Joint-history models indicated that the signal was better explained by longer-term use history than by recent use. Localization analyses indicated the connectivity effect was concentrated in dorsal thalamic regions. TMS-interaction and effective-connectivity follow-ups were null. ConclusionsReliability screening identified a thalamocortical control-network phenotype in CUD that tracks longer cocaine-use history rather than diagnosis or recent use. More broadly, this workflow offers a practical framework for screening candidate circuit-level psychiatric phenotypes for reliability.

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

1
Frontiers in Psychiatry
83 papers in training set
Top 0.1%
14.8%
2
Biological Psychiatry: Cognitive Neuroscience and Neuroimaging
62 papers in training set
Top 0.1%
14.4%
3
Drug and Alcohol Dependence
37 papers in training set
Top 0.1%
10.5%
4
Nature Mental Health
18 papers in training set
Top 0.1%
10.1%
5
Translational Psychiatry
219 papers in training set
Top 0.5%
10.1%
50% of probability mass above
6
Human Brain Mapping
295 papers in training set
Top 2%
4.0%
7
JAMA Network Open
127 papers in training set
Top 0.8%
4.0%
8
Biological Psychiatry
119 papers in training set
Top 0.8%
4.0%
9
Neuropsychopharmacology
134 papers in training set
Top 0.9%
3.6%
10
American Journal of Psychiatry
20 papers in training set
Top 0.1%
2.7%
11
Addiction Biology
47 papers in training set
Top 0.4%
2.1%
12
The British Journal of Psychiatry
21 papers in training set
Top 0.4%
2.1%
13
Biological Psychiatry Global Open Science
54 papers in training set
Top 0.4%
2.1%
14
European Journal of Neuroscience
168 papers in training set
Top 0.4%
1.7%
15
Progress in Neuro-Psychopharmacology and Biological Psychiatry
36 papers in training set
Top 0.8%
0.9%
16
NeuroImage: Clinical
132 papers in training set
Top 4%
0.8%
17
Journal of Affective Disorders
81 papers in training set
Top 2%
0.7%
18
Schizophrenia Bulletin
29 papers in training set
Top 0.6%
0.7%
19
Communications Biology
886 papers in training set
Top 29%
0.6%
20
Computational Psychiatry
12 papers in training set
Top 0.2%
0.6%
21
Molecular Psychiatry
242 papers in training set
Top 4%
0.5%
22
Brain Imaging and Behavior
14 papers in training set
Top 0.3%
0.5%
23
Scientific Reports
3102 papers in training set
Top 80%
0.5%
24
Addiction
25 papers in training set
Top 0.4%
0.5%
25
Frontiers in Pharmacology
100 papers in training set
Top 6%
0.5%